4//SEC Filing
MACKENZIE GREGORY SCOTT 4
Accession 0001209191-22-000993
CIK 0000019411other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:17 PM ET
Size
5.9 KB
Accession
0001209191-22-000993
Insider Transaction Report
Form 4
MACKENZIE GREGORY SCOTT
Director
Transactions
- Disposition to Issuer
Ordinary Common Stock, $0.01 par value
2022-01-04−10,594→ 0 total
Footnotes (2)
- [F1]In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among the Issuer, Centene Corporation ("Centene") and Mayflower Merger Sub, Inc. ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the "Common Stock") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the "Merger Consideration").
- [F2]Includes 2,911 restricted shares of Common Stock. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration.
Documents
Issuer
MAGELLAN HEALTH INC
CIK 0000019411
Entity typeother
Related Parties
1- filerCIK 0001317743
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:17 PM ET
- Size
- 5.9 KB